Iovance Biotherapeutics: An Unproven Biopharmaceutical Company With Significant Upside
25 Mar 2022 09:36 GMT
… Biotherapeutics was initially known as Genesis Biopharma. After that, the company transitioned … surprising, seeing negatives on the income statement never gives investors a … revenue with zero profits, constantly posting negatives in net income, and dealing …
Autologous Stem Cell and Non-Stem Cell Based Therapies Market is Projected to Reach US$ 4.5 Billion Globally By 2022
07 Nov 2017 19:43 GMT
… organ cells square measure used profitably to mend the damages because … FIBROCELL (U.S.) 11.7 GENESIS BIOPHARMA (U.S.) 11.8 GEORGIA …
Zacks Investment Research Lowers Lion Biotechnologies Inc (LBIO) to Sell
09 May 2017 18:03 GMT
… Biotechnologies, Inc., formerly known as Genesis Biopharma, Inc., is based in Woodland … (NASDAQ:LBIO) last released its earnings results on Monday, May 1st … Biotechnologies will post ($1.37) earnings per share for the current …